Genetics
CETP Taq1B B1B1 genotype independently predicts coronary artery disease in Koreans (Clin Genet 2003)
Original title: The association of cholesteryl ester transfer protein polymorphism with high-density lipoprotein cholesterol and coronary artery disease in Koreans
This study determined the frequency of the CETP Taq1B polymorphism in Koreans and its relationship with HDL-cholesterol and coronary artery disease (CAD), examining genotypes, lipid profiles, and other risk factors in one hundred and nineteen CAD patients and 106 controls. Genotype frequencies (B1B1:B1B2:B2B2) were 35.5%:50%:14.5% in males and 34.7%:42.6%:22.7% in females, comparable to other ethnic groups. The B1B1 homozygote was associated with significantly lower HDL-cholesterol in females (p=0.049) and non-smoking males (p=0.037), remaining significant after controlling for gender, BMI, and smoking (p=0.046), explaining 5.4% of HDL-cholesterol variation. By univariate analysis, B1B1 significantly predicted CAD (p=0.043), confirmed by multivariate analysis as an independent predictor (p=0.026, OR=1.97, 95% CI 1.08-3.57). The authors conclude the CETP Taq1B B1B1 genotype is associated with low HDL-cholesterol and may be an independent genetic CAD risk factor in Koreans.
Original abstract
Cholesteryl ester transfer protein (CETP) is a key protein involved in high-density lipoprotein cholesterol (HDL-C) metabolism. It is known to affect plasma HDL-C levels, and its genetic regulation may be involved in the development of coronary artery disease (CAD). The aim of this study was to determine the frequency of the CETP Taq1B polymorphism in Koreans, and to investigate its relationship with plasma HDL-C levels and CAD. One-hundred and nineteen patients with significant CAD and 106 controls were examined with respect to their genotypes, lipid profiles and other risk factors of CAD. The genotype frequencies of B1B1:B1B2:B2B2 in males and females were 35.5%:50%:14.5% and 34.7%:42.6%:22.7%, respectively, which is comparable to previous reports in other ethnic groups. The B1B1 homozygote was associated with significantly lower HDL-C levels in females (p = 0.049) and non-smoking males (p = 0.037). After controlling for gender, body mass index (BMI) and smoking, the TaqIB polymorphism was still significantly associated with HDL-C levels (p = 0.046) and explained 5.4% of the HDL-C variation in this study. By univariate analysis, the B1B1 homozygote was a significant predictor of CAD (p = 0.043), and this was confirmed by multivariate analysis with traditional risk factors, i.e. the B1B1 homozygote was an independent predictor of CAD (p = 0.026, odds ratio = 1.97, 95% confidence interval: 1.08-3.57). In conclusion, the B1B1 homozygote of the CETP Taq1B polymorphism is associated with low HDL-C levels in females and non-smoking males, and may be an independent genetic risk factor of CAD in the Korean population.
Summary written by cetpinhibition.org from the published abstract; figures as published. Page updated 19 August 2026. Methods.